The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce trigl ...
The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.